iOnctura picks up Series A

iOnctura B.V., a Swiss clinical stage biopharmaceutical company, has raised 15 million euros in Series A financing.

23 January 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles